1. Editor's page

   EditorialNotes Pages: 1 - 1

2. Adjuvant systemic therapy: State of the art, 1989

   • I. Craig Henderson

   11th San Antonio Breast Cancer Symposium lecture Pages: 3 - 22

3. Chemoprevention of breast cancer

   • Trevor J. Powles
   • Janet R. Hardy
   • Jennifer G. Treleaven

   11th San Antonio Breast Cancer Symposium Pages: 23 - 31

4. Megestrol acetate in breast cancer — A panel discussion

   • William L. McGuire
   • Patricia A. Johnson
   • C. Kent Osborne

   Viewpoints Pages: 33 - 38

5. Heritability of breast cancer and its role in pre-menopausal cases

   • F. J. H. Sluijter
   • J. W. Koten
   • W. Den Otter

   Comment Pages: 39 - 41

6. Hormone prevention of mammary carcinogenesis by norethynodrel-mestranol

   • Irma H. Russo
   • James Frederick
   • Jose Russo

   Report Pages: 43 - 56

7. Genomic DNA analysis of the estrogen receptor gene in breast cancer

   • Fritz F. Parl
   • Douglas R. Cavener
   • William D. Dupont

   Report Pages: 57 - 64

8. Antiestrogenic properties of keoxifene,trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells

   • Richard Poulin
   • Yves Merand
   • Fernand Labrie

   Report Pages: 65 - 76

9. Prognostic value of epidermal growth factor receptor in node-positive breast cancer

   • M. Grimaux
   • S. Romain
   • H. Magdelénat

   Report Pages: 77 - 90

10. Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications

    • Lise Pedersen
    • Susanne Holck
    • Henning T. Mouridsen

    Report Pages: 91 - 99

11. Histone acetylation decreased by estradiol in the MCF-7 human mammary cancer cell line

    • J. R. Pasqualini
    • P. Mercat
    • N. Giambiagi

    Brief communication Pages: 101 - 105

12. Program

    12th Annual San Antonio Breast Cancer Symposium December 7–9, 1988 Pages: 109 - 132

13. Abstracts

    12th Annual San Antonio Breast Cancer Symposium December 7–9, 1988 Pages: 133 - 187